Thromboxane production in morbidly obese subjects

American Journal of Cardiology

Volumn 107, Issue 11, 2011, Pages 1656-1661

  Graziani, Francesca ^a   Biasucci, Luigi M ^a   Cialdella, Pio ^a   Liuzzo, Giovanna ^a   Giubilato, Simona ^a   Della Bona, Roberta ^a   Pulcinelli, Fabio M ^b   Iaconelli, Amerigo ^a   Mingrone, Geltrude ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THROMBOXANE A2; THROMBOXANE B2; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FASTING PLASMA GLUCOSE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; MALE; MORBID OBESITY; PHYSICAL EXAMINATION; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE ACTIVATION; WAIST CIRCUMFERENCE;

ADULT; ATHEROSCLEROSIS; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; OBESITY, MORBID; THROMBOXANE A2; THROMBOXANE B2;

EID: 79956132902     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.01.053     Document Type: Article

References (26)

1. P.M. Cummings, B.H. Le, and M.B. Lopes Postmortem findings in morbidly obese individuals dying after gastric bypass procedures Hum Pathol 38 2007 593 597 (Pubitemid 46399886)
2. J. Duflou, R. Virmani, I. Rabin, A. Burke, A. Farb, and J. Smialek Sudden death as a result of heart disease in morbid obesity Am Heart J 130 1995 306 313
3. M.L. Kortelainen Myocardial infarction and coronary pathology in severely obese people examined at autopsy Int J Obes Relat Metab Disord 26 2002 73 79
4. A. Maseri, S. Chierchia, and G. Davies Pathophysiology of coronary occlusion in acute infarction Circulation 73 1986 233 239 (Pubitemid 16127398)
5. 2 and other eicosanoids Eur Heart J 14 Suppl K 1993 88 93 (Pubitemid 24038961)
6. G. Dav, M.T. Guagnano, G. Ciabattoni, S. Basili, A. Falco, M. Marinopiccoli, M. Nutini, S. Sensi, and C. Patrono Platelet activation in obese women, role of inflammation and oxidant stress Jama 288 2002 2008 2014 (Pubitemid 35204691)
7. S. Basili, G. Pacini, M.T. Guagnano, M.R. Manigrasso, F. Santilli, C. Pettinella, G. Ciabattoni, C. Patrono, and G. Dav Insulin resistance as a determinant of platelet activation in obese women J Am Coll Cardiol 48 2006 2531 2538 (Pubitemid 44881227)
8. C.J. Lavie, R.V. Milani, and H.O. Ventura Obesity and cardiovascular disease: risk factor, paradox and impact of weight loss J Am Coll Cardiol 53 2009 1925 1932
9. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 29 Suppl 1 2006 S43 S48
10. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
11. S. Konstantinides, K. Schfer, S. Koschnick, and D.J. Loskutoff Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity J Clin Invest 108 2001 1533 1540 (Pubitemid 33091991)
12. M. Nakata, T. Yada, N. Soejima, and I. Maruyama Leptin promotes aggregation of human platelets via the long form of its receptor Diabetes 48 1999 426 429 (Pubitemid 29061122)
13. M. Ozata, F. Avcu, O. Durmus, I. Yilmaz, I.C. Ozdemir, and A. Yalcin Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency Obes Res 9 2001 627 630 (Pubitemid 33603874)
14. S.S. Martin, A. Quasim, and M.P. Reilly Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease J Am Coll Cardiol 52 2008 1201 1210
15. A. Corsonello, F. Perticone, A. Malara, D. De Domenico, S. Loddo, M. Buemi, R. Ientile, and F. Corica Leptin-dependent platelet aggregation in healthy, overweight and obese subjects Int J Obes Relat Metab Disord 27 2003 566 573 (Pubitemid 36561013)
16. F. Corica, A. Corsonello, M. Lucchetti, A. Malara, D. De Domenico, L. Cannav, S. Foti, A. Valenti, R. Ientile, and A. Saitta Relationship between metabolic syndrome and platelet responsiveness to leptin in overweight and obese patients Int J Obes 31 2007 842 849 (Pubitemid 46663814)
17. B. Canavan, O.S. Raneem, S. Sunita, P. Koutkia, I. Lipinska, M. Laposata, and S. Grinspoon Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation J Clin Endocrinol Metab 90 2005 5779 5785 (Pubitemid 41415492)
18. A. Corsonello, and F. Corica Leptin obesity and platelet responsiveness: another piece in the puzzle Thromb Haemost 100 2008 960 961
19. C. Dellas, K. Schfer, I. Rohm, M. Lankeit, T. Ellrott, V. Faustin, J. Riggert, G. Hasenfuss, and S. Konstantinides Absence of leptin resistance in platelets from morbidly obese individuals may contribute to the increased thrombosis risk in obesity Thromb Haemost 100 2008 1123 1129
20. G. Giandomenico, C. Dellas, R.-P. Czekay, S. Koschnick, and D.J. Loskutoff The leptin receptor system of human platelets J Thromb Haemost 3 2005 1042 1049 (Pubitemid 41632837)
21. L.M. Biasucci, F. Graziani, V. Rizzello, G. Liuzzo, C. Guidone, A.R. De Caterina, S. Brugaletta, G. Mingrone, and F. Crea Paradoxical preservation of vascular function in severe obesity Am J Med 123 2010 727 734
22. J. Faintuch, P.C. Marques, L.A. Bortolotto, J.J. Faintuch, and I. Cecconello Systemic inflammation and cardiovascular risk factors: are morbidly obese subjects different? Obes Surg 18 2008 854 862
23. S. Shantikumar, P.J. Grant, A.J. Catto, J.M. Bamford, and A.M. Carter Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation Stroke 40 2009 977 979
24. E.L. Grove, A.M. Hvas, H.L. Johnse, S.S. Hadegaard, S.B. Pedersen, J. Mortensen, and S.D. Kristensen A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease Thromb Haemost 103 2010 1245 1253
25. G. Kidson-Gerber, J. Weaver, R. Gemmel, A.M. Prasan, and B.H. Chong Serum thromboxane B2 compared to five other platelet function tests for the evaluation of aspirin effect in stable cardiovascular disease Heart Lung Circ 19 2010 234 242
26. F.M. Pulcinelli, L.M. Biasucci, S. Riondino, S. Giubilato, A. Leo, L. Di Renzo, E. Trifir, T. Mattiello, D. Pitocco, G. Liuzzo, G. Ghirlanda, and F. Crea COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment Eur Heart J 30 2009 1279 1286